Dianthus Therapeutics (87E.F) Q4 2023 Earnings

21MarConfirmed
Q4 2023
-0.87
-0.79
-0.72
-0.65

Details

Expected EPS
-0.86527
Actual EPS
-0.653555
Surprise EPS
0.21
Surprise Percent
+24.47%

Description

Dianthus Therapeutics (87E.F) has reported earnings of -0.653555 per share for Q4 2023.

0 Comments

Share your thoughts